Idiopathic Pulmonary Fibrosis

This report displays the potential drug interactions for the following 2 drugs: interferon gamma-1b Paracetamol (acetaminophen) Edit list (add/remove drugs) Interactions between your drugs No interactions were found between interferon gamma-1b and Paracetamol. This does not necessarily mean no interactions exist. Always consult your healthcare provider. interferon gamma-1b A total of 143 drugs are known […]

Merkel cell polyomavirus (MCPyV) is the causative agent of an aggressive skin tumor, Merkel cell carcinoma (MCC). The viral genome is integrated into the tumor genome and harbors nonsense mutations in the helicase domain of large T antigen (LTAg). However, the molecular mechanisms by which the viral genome gains the tumor-specific mutations remain to be […]

Objective: Studies indicate that caffeine uptake may be a risk factor for rheumatoid arthritis (RA), but a definitive link between caffeine consumption and RA has not been established. This study aimed to investigate the interplay between caffeine, adenosine receptor A2a, and interferon-γ (IFN-γ) production in CD4+ T cells from RA patients. Method: Peripheral blood mononuclear […]

Aims To evaluate the efficacy and safety of nintedanib plus docetaxel in patients with advanced adenocarcinoma non-small cell lung cancer (NSCLC) who progressed after chemotherapy and immune checkpoint inhibitor (ICI) therapy. Materials and methods VARGADO (NCT02392455) is an ongoing, prospective, non-interventional, real-world study of nintedanib plus docetaxel after first-line chemotherapy in the routine clinical treatment […]

12.1 Mechanism of Action The mechanism of action of pirfenidone in the treatment of IPF has not been established. 12.2 Pharmacodynamics Cardiac Electrophysiology The effect of pirfenidone on QT interval was evaluated in a randomized, placebo, and positive controlled parallel study in 160 healthy adult volunteers. Volunteers received pirfenidone 2,403 mg/day (recommended dose) and 4,005 […]

Pirfenidone Pirfenidone Pirfenidone is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Pirfenidone. Product ID 60219-1642_5d423ea4-5071-42f8-86fb-669381c7657c NDC 60219-1642 Product Type Human Prescription Drug Proprietary Name Pirfenidone Generic Name Pirfenidone Dosage Form Capsule Route of Administration ORAL Marketing Start Date 2022-01-07 […]

Biotherapeutics company PureTech Health said results from a study showed that approximately 50% fewer subjects treated with its LYT-100 drug experienced gastrointestinal-related adverse events compared to subjects treated with pirfenidone. Pirfenidone is approved by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, an orphan disease that is ‘chronic and progressive […]

Pesticides are the only hazardous substances that are intentionally discharged in a significant amount into the environment. The accumulation of these contaminants in different body organs, eggs, and prey samples of avian species has been reported worldwide. Carbamates, organophosphates, and organochlorines are commonly used pesticides. Organophosphates have been used extensively as pesticides for forty years […]

$350.00 Usually Ships in 1-5 Days Description This reference spotlights the immunologic aspects of applying interferon-gamma to the treatment of infectious diseases – revealing the current knowledge of the biology and potential utility of interferon-gamma.;Written by more than 30 leading investigators in the field, Anti-Infective Applications of Interferon-Gamma: presents information according to specific patient populations […]

US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis AU2002347182A1 (en) * 2001-12-18 2003-06-30 Mondobiotech Licensing Out Ag Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases CA2496577A1 (en) * 2002-08-28 […]

AbstractBovine tuberculosis (BTB) caused by Mycobacterium bovis remains a major problem in both the developed and developing countries. Control of BTB in the UK is carried out by test and slaughter of infected animals, based primarily on the tuberculin skin test (PPD). Vaccination with the attenuated strain of the M. bovis pathogen, BCG, is not […]

Background: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis (IPF) has been established by multiple clinical trials. This study aims to assess the efficacy and safety of nintedanib in real-world IPF patients in India. Methods: Clinical records of IPF patients (prescribed with nintedanib) visiting tertiary pulmonary care center, between June 2016 and December 2019, […]

Abstract Foot and mouth disease (FMD) is one of the most contagious diseases of cloven footed animals causing significant economic impediment in livestock production system. The immune response to FMD virus (FMDV) infection is regulated by a complex interplay between various cells, cytokines and other immune components. Based on the well established role of Interferon-gamma […]

Association of interferon-gamma gene polymorphisms with susceptibility to oral lichen planus in the Thai population ประเภทเอกสาร บทความในวารสาร 10.1016/j.archoralbio.2011.10.009 ชื่อวารสาร ฉบับที่/หน้า ปีที่ 57 ฉบับที่ 5 หน้า 491-494 วารสารออนไลน์: ดรรชนี-อังกฤษ Interferon-γ;Oral lichen planus;Polymorphism;gamma interferon;allele;article;case control study;chi square distribution;female;gene frequency;genetic predisposition;genetics;genotype;human;lichen planus;male;middle aged;polymerase chain reaction;single nucleotide polymorphism;Thailand;Alleles;Case-Control Studies;Chi-Square Distribution;Genetic Predisposition to Disease;Humans;Interferon-gamma;Lichen Planus, […]

Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease – Fingerprint — University of Edinburgh Research Explorer Sort by Weight Alphabetically Medicine & Life Sciences nintedanib 100% Interstitial Lung Diseases 68% Placebos 43% Randomized Controlled Trials 42% Vital Capacity 41% Child 27% Pulmonary Arterial Hypertension 14% […]

FOR THE early detection of latent tuberculosis infection (LTBI) among households in Mumbai, the Brihanmumbai Municipal Corporation (BMC) is for the first time initiating compulsory screening of family members of active pulmonary tuberculosis (TB) patients from January 1, 2022. This could be a game changer by reducing the TB burden by half in the city. […]

SNOMED code 718230004 name Mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency status active date introduced 2016-07-31 fully specified name(s) Mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency (disorder) synonyms Mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency Mendelian susceptibility […]

Product Description We manufacture and supply the qualitative capsules and injections to our consumer that is formulated with best quality required materials with the help of latest technology. It is utilized to treat a specific lung infection (idiopathic pneumonic fibrosis). Additionally, the medicine is used to treat interstitial lung infection individuals with scleroderma. Offered Nintedanib […]

Name Interferon Gamma Antibody (GWB-820AA8) Related Product Names MOUSE ANTI HUMAN INTERFERON GAMMA IFN GAMMA Gene Symbol IFNG Gene Family IFN Gene id 3458 Alias Symbols IFG, IFI, IFNG Swissprot ID P01579 Protein Name Interferon gamma Description of Target MOUSE ANTI HUMAN INTERFERON GAMMA Protein Accession Num NP_000610.2 Clone D9D10 Application Info Flow Cytometry(1): 1/10 […]

Self-Paced Learning: Antiviral Nutrition Protocol Structure, Science, Application We all need a better understanding of viral infections, especially now Whether we are doctors or patients, we all have an interest in viral infections because of their prevalence in the population and also their clinical consequences. However, my experience/observation is that most people don’t understand the […]